M. MacMillan

发表

Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.

Jakub Tolar, John E Wagner, Thomas Scholl, 2004, Blood.

Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor hematopoietic cell transplantation for Fanconi anemia.

J. Wagner, K. Dusenbery, M. MacMillan, 2015, Blood.

Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I–II clinical trial

J. Wagner, M. MacMillan, B. Blazar, 2009, Bone Marrow Transplantation.

Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations

J. Wagner, M. MacMillan, H. Zierhut, 2017, American journal of medical genetics. Part A.

Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations

J. Wagner, C. Ebens, M. MacMillan, 2017, Expert review of hematology.

Hematopoietic Cell Transplantation for Fanconi Anemia

J. Wagner, J. Tolar, A. Auerbach, 2007 .

Chronic Graft-Versus-Host Disease, Non-Relapse Mortality and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A CIBMTR Analysis.

J. Pidala, L. Lekakis, V. Bhatt, 2021, Transplantation and cellular therapy.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.

M. Norkin, H. Nakasone, M. Aljurf, 2018, Blood advances.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

D. Kaufman, J. Wagner, K. Dusenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

H. Deeg, E. Guinan, B. George, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor and Recipient Plasma Follistatin Levels are Associated with Acute Graft-versus-Host Disease in Blood and Marrow Transplant Clinical Trials Network 0402

G. Vercellotti, M. MacMillan, Juan Wu, 2017, Bone Marrow Transplantation.

A refined risk score for acute GVHD that predicts response to initial therapy, survival and transplant-related mortality

M. Robin, M. Pasquini, Richard J. Jones, 2015 .

Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.

V. Brown, R. Gale, S. Gadalla, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

R. Vij, D. Lad, M. Perales, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key

M. MacMillan, Jo-Anne H. Young, Asmaa Ferdjallah, 2021, Frontiers in Pediatrics.

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2021, Blood advances.

Human in vitro-induced regulatory T cells display Dlgh1 dependent and PKC-θ restrained suppressive activity

Sudha Kumari, Michael Loran Dustin, M. MacMillan, 2017, Scientific Reports.

Regulatory T cells: A review of manufacturing and clinical utility

J. Wagner, T. Mamo, Jeffrey S. Miller, 2022, Transfusion.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

J Wagner, J. Wagner, C. Eide, 2002, Blood.

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study

J. Lai, M. MacMillan, K. Baird, 2014, Supportive Care in Cancer.

Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation.

A. Khoruts, C. Staley, M. MacMillan, 2022, Transplantation and cellular therapy.

Predictors and outcomes of flares in chronic graft-versus-host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2020, Bone Marrow Transplantation.

Interleukin‐1 genotype and outcome of unrelated donor bone marrow transplantation

M. MacMillan, S. Davies, D. Weisdorf, 2003, British journal of haematology.

Endpoints for Clinical Trials Testing Treatment of Acute Graft- versus-host Disease: A Consensus Document

R. Soiffer, P. McCarthy, M. MacMillan, 2010 .

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

E. Shpall, R. Soiffer, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2009, Blood.

Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.

M. MacMillan, S. Davies, D. Confer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2019, JCI insight.

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis

J. Wagner, M. MacMillan, B. Hirsch, 2007, American journal of hematology.

Graft Versus Host Disease: From Basics to the Clinic

E. Guinan, M. MacMillan, 2014 .

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

Walker S. Lahr, Beau R. Webber, Mitchell G. Kluesner, 2022, International journal of molecular sciences.

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

M. Sorror, M. MacMillan, T. Gooley, 2022, Blood advances.

Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease: single-center results from a cohort of 203 patients.

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.

H. Deeg, T. Fleming, J. Dipersio, 2007, Blood.

Management of acute graft-versus-host disease in children.

M. MacMillan, P. Carpenter, 2010, Pediatric clinics of North America.

Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies.

M. MacMillan, E. Gluckman, M. Walters, 2010, Seminars in hematology.

In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines

J. Wagner, D. Munn, B. Levine, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.

J. Wagner, J. Steinberger, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.

A. Khoruts, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.

J. L. Goodman, M. MacMillan, D. Weisdorf, 2002, The American journal of medicine.

Follistatin and Soluble Endoglin Predict 1-year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant.

Jeffrey S. Miller, M. MacMillan, Juan Wu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis.

M. Perales, J. Pidala, C. Abboud, 2022, Transplantation and cellular therapy.

High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation

M. MacMillan, S. Davies, W. Kiffmeyer, 2003, Transplantation.

graft-versus-leukemia effect in recipients of 2 units Relapse risk after umbilical cord blood transplantation: enhanced

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2013 .

Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.

D. Kaufman, J. Wagner, K. Dusenbery, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.

Thomas E Heineman, M. Imieliński, A. Koren, 2022, Nature.

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

S. Grupp, D. Porter, M. Pasquini, 2014, Blood.

Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS

J. Wagner, M. MacMillan, M. Verneris, 2013, Pediatric blood & cancer.

More than 10 Years After the First ‘Savior Siblings’: Parental Experiences Surrounding Preimplantation Genetic Diagnosis

J. Wagner, M. MacMillan, D. Bartels, 2013, Journal of Genetic Counseling.

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

S. Grupp, D. Porter, M. Pasquini, 2012 .

Growth hormone treatment of patients with Fanconi Anemia after hematopoietic cell transplantation

J. Wagner, G. Forlenza, M. MacMillan, 2014, Pediatric blood & cancer.

Haematopoeitic cell transplantation for Fanconi anaemia – when and how?

J. Wagner, M. MacMillan, 2010, British journal of haematology.

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

J. Wagner, J. Tolar, M. MacMillan, 2009 .

Alternate Donor HSCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study.

J. Wagner, J. Tolar, M. MacMillan, 2007 .

Thymic Shielding (TS) in Recipients of Total Body Irradiation (TBI) and Alternative Donor Hematopoietic Stem Cell Transplant (AD-HSCT): Reduced Risk of Opportunistic Infection in Patients with Fanconi Anemia (FA).

J. Wagner, K. Dusenbery, M. MacMillan, 2006 .

Successful engraftment without radiation after fludarabine‐based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation

J. Wagner, A. Auerbach, M. MacMillan, 2006, Pediatric blood & cancer.

Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis.

J. Wagner, J. Kahn, M. MacMillan, 2004, Blood.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce

N. Geller, P. Hari, D. Porter, 2019, The Lancet. Haematology.

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

G. Vercellotti, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source.

J. Wagner, R. Hough, M. MacMillan, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chronic graft-versus-host disease: a prospective cohort study.

M. MacMillan, S. Davies, D. Weisdorf, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

J. Wagner, M. MacMillan, D. Weisdorf, 2009, Blood.

Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report

C. Ebens, M. MacMillan, M. Schleiss, 2021, BMC Infectious Diseases.

Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD.

M. Hall, S. Spellman, Tao Wang, 2021, Transplantation and cellular therapy.

Elevations in serum alpha fetoprotein levels in patients with Fanconi anaemia

J. Wagner, M. MacMillan, R. Mitchell, 2019, British journal of haematology.

Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy

S. Hecht, V. Guidolin, P. Villalta, 2023, Molecular Therapy Oncolytics.

Fanconi Anemia Pathway Deficiency Drives Copy Number Variation in Squamous Cell Carcinomas

Thomas E Heineman, P. Campbell, M. Imieliński, 2021, bioRxiv.

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

D. Zahrieh, R. Soiffer, Stephanie J. Lee, 2004, Blood.

Cellular therapy for fanconi anemia: the past, present, and future.

G. Daley, Suneet Agarwal, M. Hughes, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study.

J. Wagner, J. Kurtzberg, C. Niemeyer, 2010, Blood.

J. Wagner, A. Auerbach, M. MacMillan, 2007, Blood.

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnostic peritoneal lavage for assessing acute abdomen in pediatric oncology and stem cell transplantation patients.

J. Neglia, D. Saltzman, M. MacMillan, 2004, Journal of pediatric hematology/oncology.

Comprehensive Analysis of Pathogenic Deletion Variants in Fanconi Anemia Genes

E. Ostrander, N. Narisu, J. Wagner, 2014, Human mutation.

Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.

O. Ringdén, Tao Wang, M. MacMillan, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fatal Hemorrhage from Androgen-Related Hepatic Adenoma After Hematopoietic Cell Transplantation

J. Wagner, A. Auerbach, M. MacMillan, 2004, Journal of pediatric hematology/oncology.

Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.

C. Le, J. Wagner, B. Levine, 2016, Blood.

Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation.

M. MacMillan, A. Alousi, M. Horwitz, 2021, Transplantation and cellular therapy.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.

J. Wagner, M. MacMillan, S. Davies, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.

J. Wagner, M. MacMillan, B. Hirsch, 2010, American journal of clinical pathology.

Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial

J. Wagner, K. Dusenbery, M. MacMillan, 2000, British journal of haematology.

Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.

J. Wagner, M. MacMillan, M. Verneris, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

M. MacMillan, D. Weisdorf, C. Ustun, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.

J. Wagner, Jeffrey S. Miller, M. MacMillan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pediatric acute GVHD: clinical phenotype and response to upfront steroids

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Bone Marrow Transplantation.

Validation of Minnesota acute graft-versus-host disease Risk Score

M. MacMillan, D. Weisdorf, B. Blazar, 2019, Haematologica.

GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

M. Aljurf, I. Lewis, R. Gale, 2016, Bone Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.

M. Robin, M. Pasquini, Richard J. Jones, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

M. MacMillan, D. Weisdorf, T. DeFor, 2012, British journal of haematology.

Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid

A. Khoruts, C. Forster, M. MacMillan, 2018, Modern Pathology.

The best endpoint for acute GVHD treatment trials.

M. MacMillan, D. Weisdorf, T. DeFor, 2010, Blood.

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2018, Haematologica.

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Blood advances.

Patient interleukin‐18 GCG haplotype associates with improved survival and decreased transplant‐related mortality after unrelated‐donor bone marrow transplantation

J. Bidwell, M. MacMillan, D. Weisdorf, 2004, British journal of haematology.

Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501.

E. Leifer, M. Horowitz, J. Pidala, 2019, Blood.

Interleukin‐1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia

J. Klein, M. MacMillan, S. Davies, 2007, British journal of haematology.

Hematopoietic cell transplantation for congenital bone marrow failure

J. Wagner, M. MacMillan, 2005, Current opinion in oncology.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fanconi anemia: correlating central nervous system malformations and genetic complementation groups

M. MacMillan, R. Gawande, D. Nascene, 2017, Pediatric Radiology.

Formation of cyclophosphamide specific DNA adducts in hematological diseases

N. Tretyakova, J. Wagner, M. MacMillan, 2012, Pediatric blood & cancer.

Costs of pediatric allogeneic hematopoietic‐cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2010, Pediatric blood & cancer.

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant

J. Wagner, J. Tolar, M. MacMillan, 2011, Bone Marrow Transplantation.

A Novel Triple Umbilical Cord Blood Transplant (UCBT) Strategy To Promote NK Cell Immunotherapy (Unit 1) with a Fully Ablative Preparative Regimen Followed by a Double UCBT in Patients with Refractory AML.

C. Le, K. Dusenbery, Jeffrey S. Miller, 2006 .

Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients.

R. Krance, M. MacMillan, S. Davies, 2011, Blood.

Dyskeratosis Congenita: Low Regimen-Related Toxicity Following Hematopoietic Cell Transplantation (HCT) Using a Reduced Intensity Conditioning Regimen.

J. Wagner, J. Tolar, B. Alter, 2007 .

Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.

J. Wagner, C. Ebens, M. MacMillan, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intractable hemorrhagic cystitis after hematopoietic stem cell tranplantation--is there a role for early urinary diversion in children?

M. MacMillan, Angela R. Smith, Stephen J Lukasewycz, 2012, The Journal of urology.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

Low 5-year health care burden after umbilical cord blood transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Blood advances.

Stress responses , M 2 macrophages , and a distinct microbial signature in fatal intestinal acute graft-versus-host disease

A. Khoruts, M. MacMillan, D. Weisdorf, 2019 .

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.

Beau R. Webber, J. Wagner, J. Tolar, 2016, Stem cells and development.

Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia

M. Loh, A. Olshen, M. Sulis, 2020, Haematologica.

Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency

Hanh T. Nguyen, D. Largaespada, K. Shannon, 2016, Haematologica.

Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children

S. Gadalla, M. MacMillan, S. Davies, 2020, Haematologica.

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

M. Aljurf, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Steroid sensitive acute GVHD, but not steroid dependent or steroid resistant, results in similar infection risk as no GVHD following allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, M. Arora, 2022, Transplantation and cellular therapy.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2014, Leukemia & lymphoma.

New Classification of Chronic Graft Versus Host Disease: Added Clarity from the Consensus Diagnoses.

M. MacMillan, D. Weisdorf, M. Arora, 2007 .

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

P. Westervelt, M. Pasquini, M. Horowitz, 2014, Blood.

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial

J. Wagner, D. Douek, M. MacMillan, 2007, Bone Marrow Transplantation.

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease

M. MacMillan, D. Weisdorf, B. Blazar, 2022, Journal of cutaneous pathology.

Influence of antiidiotypic antibody activity on renal transplant outcome.

A. Macleod, M. MacMillan, G. Catto, 1991, Kidney international.

Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation.

J. Kurtzberg, C. Martinez, M. Pasquini, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation in Fanconi Anemia Patients with Biallelic BRCA2 Mutations.

J. Wagner, A. Auerbach, M. MacMillan, 2004 .

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Bone Marrow Transplantation.

Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.

R. Gale, J. Pidala, L. Lekakis, 2022, Transplantation and cellular therapy.

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2016, Bone Marrow Transplantation.

Hematopoietic Stem Cell Transplant for Shwachman Diamond Syndrome.

M. MacMillan, K. Myers, M. Eapen, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.

M. MacMillan, S. Davies, P. Mehta, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

J. Wagner, M. MacMillan, Richard E. Harris, 2004 .

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Avis J. Thomas, J. Wagner, J. Tolar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late-onset Acute and Chronic Graft-Versus-Host Disease in Children: Clinical features and Response to Therapy.

M. MacMillan, D. Weisdorf, M. Arora, 2021, Transplantation and cellular therapy.

Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia

J. Wagner, M. MacMillan, B. Hirsch, 2014, British journal of haematology.

Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion.

J. Wagner, S. Furlan, E. Wang, 2021, Cytotherapy.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

J. Wagner, Chi Chen, G. Vercellotti, 2020, Blood advances.

Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis

Robin R. Shields-Cutler, D. Knights, A. Khoruts, 2020, British journal of haematology.

Paternal or Maternal Uniparental Disomy of Chromosome 16 Resulting in Homozygosity of a Mutant Allele Causes Fanconi Anemia

E. Ostrander, J. Wagner, A. Auerbach, 2016, Human mutation.

A Multi-Center, Randomized, Double Blind, Phase III Clinical Trial Comparing Steroids/Placebo Vs. Steroids/Mycophenolate Mofetil As Initial Therapy for Acute Graft-Versus-Host Disease. Blood and Marrow Transplant Clinical Trials Network Study 0802

P. Westervelt, M. Pasquini, M. Horowitz, 2013 .

Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-Versus-Host Disease.

M. MacMillan, D. Weisdorf, B. Blazar, 2023, Transplantation and cellular therapy.

Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.

C. Ebens, G. Vercellotti, Jeffrey S. Miller, 2023, Transplantation and cellular therapy.

Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study.

M. MacMillan, D. Sumstad, D. McKenna, 2022, Transplantation and Cellular Therapy.

CD45-targeted antibody-drug-conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation.

J. Wagner, M. MacMillan, H. Kiem, 2022, Blood.

A pilot study of donor-engrafted clonal hematopoiesis evolution and clinical outcomes in allogeneic hematopoietic cell transplant recipients using a national registry.

T. Druley, Mingxiang Teng, J. Pidala, 2023, Transplantation and cellular therapy.

First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation

J. Wagner, M. MacMillan, A. Moran, 2009, Pediatric blood & cancer.

Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.

J. Wagner, M. MacMillan, B. Hirsch, 2010, American journal of clinical pathology.

Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.

J. Wagner, C. Ebens, M. MacMillan, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre‐transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft‐versus‐host disease

Benjamin M Hillmann, Robin R. Shields-Cutler, A. Khoruts, 2023, British journal of haematology.

New classification of chronic GVHD: added clarity from the consensus diagnoses

J. Witte, M. MacMillan, D. Weisdorf, 2009, Bone Marrow Transplantation.

Alternative donor hematopoietic cell transplantation for Fanconi anemia.

J. Wagner, K. Dusenbery, M. MacMillan, 2015, Blood.

J. Wagner, A. Auerbach, M. MacMillan, 2007, Blood.

CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia

Beau R. Webber, M. MacMillan, Mark J. Osborn, 2016 .

Idiotypic-Antiidiotypic Antibody Interaction and Renal-Transplant Survival

A. Macleod, M. MacMillan, G. Catto, 1991 .

Development of specific growth charts for children with Fanconi anemia.

M. MacMillan, Arpana Rayannavar, Crystal Barbus, 2024, American journal of medical genetics. Part A.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

What predicts high risk acute graft‐versus‐host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

M. MacMillan, D. Weisdorf, T. Defor, 2012, British Journal of Haematology.

A risk-adapted approach to acute GVHD treatment: are we there yet?

M. MacMillan, S. Holtan, M. MacMillan, 2016, Bone Marrow Transplantation.

FANCA c.3624C>T (p.Ser1208=) is a hypomorphic splice variant associated with delayed onset of Fanconi anemia

A. Auerbach, M. MacMillan, S. Chandrasekharappa, 2024, Blood Advances.